acetylcysteine and 6-methyl-2-(phenylethynyl)pyridine

acetylcysteine has been researched along with 6-methyl-2-(phenylethynyl)pyridine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bray, SM; Chang, S; He, C; Jin, P; Li, Z; Warren, ST; Zarnescu, DC1
Gass, JT; Kalivas, PW; Lavin, A; Moran, M; Moussawi, K; Olive, MF; Pacchioni, A1

Other Studies

2 other study(ies) available for acetylcysteine and 6-methyl-2-(phenylethynyl)pyridine

ArticleYear
Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila.
    Nature chemical biology, 2008, Volume: 4, Issue:4

    Topics: Animals; Disease Models, Animal; Drosophila; Drosophila Proteins; Drug Evaluation, Preclinical; Female; Fragile X Mental Retardation Protein; Fragile X Syndrome; gamma-Aminobutyric Acid; Glutamic Acid; Male; Molecular Weight; Mutation; Phenotype; Pyridines; RNA, Messenger; Small Molecule Libraries

2008
N-Acetylcysteine reverses cocaine-induced metaplasticity.
    Nature neuroscience, 2009, Volume: 12, Issue:2

    Topics: Acetylcysteine; Animals; Behavior, Animal; Cocaine-Related Disorders; Disease Models, Animal; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Free Radical Scavengers; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Neuronal Plasticity; Nucleus Accumbens; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Secondary Prevention; Self Administration; Substance Withdrawal Syndrome

2009